BBIO logo

BridgeBio Pharma, Inc. (BBIO) Cash From Operations

Annual CFO:

-$520.73M+$6.99M(+1.33%)
December 31, 2024

Summary

  • As of today, BBIO annual cash from operations is -$520.73 million, with the most recent change of +$6.99 million (+1.33%) on December 31, 2024.
  • During the last 3 years, BBIO annual cash from operations has fallen by -$22.79 million (-4.58%).
  • BBIO annual cash from operations is now -1186.12% below its all-time high of -$40.49 million, reached on December 31, 2017.

Performance

1-Year Change

+1.33%

3-Year Change

-4.58%

5-Year Change

-105.34%

15-Year Change

-1186.12%

BBIO Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

0.59%
BBIO annual cash from operations is higher than 0.59% of companies in Healthcare sector

Range

All-Time High

-$40.49M
BBIO annual cash from operations is currently -1186.12% below its historical high of -$40.49 million

3-Year Low

-$527.72M
BBIO annual cash from operations is currently +1.33% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
BBIO previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

Feb 19, 2026
BBIO next annual earnings announcement is scheduled for Feb 19, 2026

OtherBBIOcash flow metrics

Annual CFI

$60.78M
BBIO annual cash from investing is $60.78 million

Annual CFF

$748.46M
BBIO annual cash from financing is $748.46 million

Annual FCF

-$529.63M
BBIO annual free cash flow is -$529.63 million

Annual CAPEX

$8.91M
BBIO annual capital expenditures is $8.91 million

Quarterly CFO:

-$109.57M-$28.89M(-35.81%)
September 30, 2025

Summary

  • As of today, BBIO quarterly cash from operations is -$109.57 million, with the most recent change of -$28.89 million (-35.81%) on September 30, 2025.
  • Over the past year, BBIO quarterly cash from operations has increased by +$70.99 million (+39.32%).
  • BBIO quarterly cash from operations is now -246.68% below its all-time high of $74.70 million, reached on June 30, 2024.

Performance

3-Month Change

-35.81%

1-Year Change

+39.32%

3-Year Change

+18.93%

5-Year Change

+16.79%

BBIO Quarterly Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

1.63%
BBIO quarterly cash from operations is higher than 1.63% of companies in Healthcare sector

Range

All-Time High

$74.70M
BBIO quarterly cash from operations is currently -246.68% below its historical high of $74.70 million

3-Year Low

-$219.54M
BBIO quarterly cash from operations is currently +50.09% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
BBIO previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Feb 19, 2026
BBIO next earnings announcement is scheduled for Feb 19, 2026

OtherBBIOcash flow metrics

Quarterly CFI

$4.46M
BBIO quarterly cash from investing is $4.46 million

Quarterly CFF

-$894.00K
BBIO quarterly cash from financing is -$894.00 thousand

Quarterly FCF

-$112.44M
BBIO quarterly free cash flow is -$112.44 million

Quarterly CAPEX

$2.87M
BBIO quarterly capital expenditures is $2.87 million

TTM CFO:

-$584.82M+$70.99M(+10.83%)
September 30, 2025

Summary

  • As of today, BBIO TTM cash from operations is -$584.82 million, with the most recent change of +$70.99 million (+10.83%) on September 30, 2025.
  • Over the past year, BBIO TTM cash from operations has dropped by -$134.60 million (-29.90%).
  • BBIO TTM cash from operations is now -3157.85% below its all-time high of -$17.95 million, reached on March 31, 2018.

Performance

3-Month Change

+10.83%

1-Year Change

-29.9%

3-Year Change

-26.78%

5-Year Change

-54.04%

BBIO TTM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

0.54%
BBIO TTM cash from operations is higher than 0.54% of companies in Healthcare sector

Range

All-Time High

-$17.95M
BBIO TTM cash from operations is currently -3157.85% below its historical high of -$17.95 million

3-Year Low

-$655.81M
BBIO TTM cash from operations is currently +10.83% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
BBIO previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Feb 19, 2026
BBIO next earnings announcement is scheduled for Feb 19, 2026

OtherBBIOcash flow metrics

TTM CFI

-$11.82M
BBIO TTM cash from investing is -$11.82 million

TTM CFF

$833.86M
BBIO TTM cash from financing is $833.86 million

TTM FCF

-$597.61M
BBIO TTM free cash flow is -$597.61 million

TTM CAPEX

$12.80M
BBIO TTM capital expenditures is $12.80 million

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

BBIO Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+1.3%+39.3%-29.9%
3Y3 Years-4.6%+18.9%-26.8%
5Y5 Years-105.3%+16.8%-54.0%

BBIO Cash From Operations Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-24.1%+1.3%-246.7%+50.1%-45.5%+10.8%
5Y5-Year-105.3%+1.3%-246.7%+50.1%-54.0%+10.8%
All-TimeAll-Time-1186.1%+1.3%-246.7%+50.1%-3157.8%+10.8%

BBIO Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2025
-
-$109.57M(-35.8%)
-$584.82M(+10.8%)
Jun 2025
-
-$80.68M(+59.5%)
-$655.81M(-31.1%)
Mar 2025
-
-$199.24M(-2.0%)
-$500.42M(+3.9%)
Dec 2024
-$520.73M(+1.3%)
-$195.33M(-8.2%)
-$520.73M(-15.7%)
Sep 2024
-
-$180.57M(-341.7%)
-$450.22M(-8.5%)
Jun 2024
-
$74.70M(+134.0%)
-$414.88M(+31.2%)
Mar 2024
-
-$219.54M(-75.9%)
-$602.93M(-14.3%)
Dec 2023
-$527.72M(-25.8%)
-$124.82M(+14.1%)
-$527.72M(-6.6%)
Sep 2023
-
-$145.23M(-28.1%)
-$495.02M(-2.1%)
Jun 2023
-
-$113.35M(+21.5%)
-$484.96M(-20.6%)
Mar 2023
-
-$144.32M(-56.7%)
-$402.06M(+4.2%)
Dec 2022
-$419.49M(+15.8%)
-$92.12M(+31.8%)
-$419.49M(+9.1%)
Sep 2022
-
-$135.16M(-343.8%)
-$461.27M(-3.0%)
Jun 2022
-
-$30.45M(+81.2%)
-$447.66M(+12.0%)
Mar 2022
-
-$161.75M(-20.8%)
-$508.92M(-2.2%)
Dec 2021
-$497.93M
-$133.90M(-10.1%)
-$497.93M(-8.2%)
DateAnnualQuarterlyTTM
Sep 2021
-
-$121.56M(-32.5%)
-$460.30M(+2.2%)
Jun 2021
-
-$91.71M(+39.2%)
-$470.42M(-0.8%)
Mar 2021
-
-$150.76M(-56.6%)
-$466.56M(-16.7%)
Dec 2020
-$399.71M(-57.6%)
-$96.26M(+26.9%)
-$399.71M(-5.3%)
Sep 2020
-
-$131.68M(-49.9%)
-$379.66M(-28.5%)
Jun 2020
-
-$87.85M(-4.7%)
-$295.47M(-6.5%)
Mar 2020
-
-$83.92M(-10.1%)
-$277.43M(-9.4%)
Dec 2019
-$253.59M(-85.6%)
-$76.20M(-60.4%)
-$253.59M(-43.0%)
Sep 2019
-
-$47.50M(+32.0%)
-$177.38M(-5.5%)
Jun 2019
-
-$69.81M(-16.2%)
-$168.21M(-27.1%)
Mar 2019
-
-$60.08M(-56.8%)
-$132.35M(-46.7%)
Dec 2018
-$136.64M(-237.5%)
-
-
Sep 2018
-
-$38.32M(-12.9%)
-$90.23M(-73.8%)
Jun 2018
-
-$33.96M(-89.2%)
-$51.91M(-189.2%)
Mar 2018
-
-$17.95M
-$17.95M
Dec 2017
-$40.49M
-
-

FAQ

  • What is BridgeBio Pharma, Inc. annual cash from operations?
  • What is the all-time high annual cash from operations for BridgeBio Pharma, Inc.?
  • What is BridgeBio Pharma, Inc. annual cash from operations year-on-year change?
  • What is BridgeBio Pharma, Inc. quarterly cash from operations?
  • What is the all-time high quarterly cash from operations for BridgeBio Pharma, Inc.?
  • What is BridgeBio Pharma, Inc. quarterly cash from operations year-on-year change?
  • What is BridgeBio Pharma, Inc. TTM cash from operations?
  • What is the all-time high TTM cash from operations for BridgeBio Pharma, Inc.?
  • What is BridgeBio Pharma, Inc. TTM cash from operations year-on-year change?

What is BridgeBio Pharma, Inc. annual cash from operations?

The current annual cash from operations of BBIO is -$520.73M

What is the all-time high annual cash from operations for BridgeBio Pharma, Inc.?

BridgeBio Pharma, Inc. all-time high annual cash from operations is -$40.49M

What is BridgeBio Pharma, Inc. annual cash from operations year-on-year change?

Over the past year, BBIO annual cash from operations has changed by +$6.99M (+1.33%)

What is BridgeBio Pharma, Inc. quarterly cash from operations?

The current quarterly cash from operations of BBIO is -$109.57M

What is the all-time high quarterly cash from operations for BridgeBio Pharma, Inc.?

BridgeBio Pharma, Inc. all-time high quarterly cash from operations is $74.70M

What is BridgeBio Pharma, Inc. quarterly cash from operations year-on-year change?

Over the past year, BBIO quarterly cash from operations has changed by +$70.99M (+39.32%)

What is BridgeBio Pharma, Inc. TTM cash from operations?

The current TTM cash from operations of BBIO is -$584.82M

What is the all-time high TTM cash from operations for BridgeBio Pharma, Inc.?

BridgeBio Pharma, Inc. all-time high TTM cash from operations is -$17.95M

What is BridgeBio Pharma, Inc. TTM cash from operations year-on-year change?

Over the past year, BBIO TTM cash from operations has changed by -$134.60M (-29.90%)
On this page